Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Claire Couty"'
Autor:
Hippolyte Darré, Perrine Masson, Arnaud Nativel, Laura Villain, Diane Lefaudeux, Claire Couty, Bastien Martin, Evgueni Jacob, Michaël Duruisseaux, Jean-Louis Palgen, Claudio Monteiro, Adèle L’Hostis
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 704 (2024)
Mutationsin epidermal growth factor receptor (EGFR) are found in approximately 48% of Asian and 19% of Western patients with lung adenocarcinoma (LUAD), leading to aggressive tumor growth. While tyrosine kinase inhibitors (TKIs) like gefitinib and os
Externí odkaz:
https://doaj.org/article/e5edff8536c445b9bec0eb00a9ed4bd5
Autor:
Simon Arsène, Claire Couty, Igor Faddeenkov, Natacha Go, Solène Granjeon-Noriot, Daniel Šmít, Riad Kahoul, Ben Illigens, Jean-Pierre Boissel, Aude Chevalier, Lorenz Lehr, Christian Pasquali, Alexander Kulesza
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
A computational mechanistic viral infection model and trial simulation advocates for adaptation of respiratory disease clinical trials whose chances of success and interpretability are being degraded under COVID-19 pandemic mitigation measures.
Externí odkaz:
https://doaj.org/article/37c68ec1231844d3bb89463c45bc7ac0
Autor:
Perrine Masson, Claire Couty, Arnaud Nativel, Evgueni Jacob, Raphaël Toueg, Michaël Duruisseaux, Adèle L'Hostis, Jean-Louis Palgen, Claudio Monteiro
Publikováno v:
Cancer Research. 83:859-859
Introduction Epidermal growth factor receptor (EGFR) mutations occur in about 40% of Asian and 13-25% of Western patients with lung adenocarcinoma (LUAD) [1,2]. EGFR tyrosine kinase inhibitors (TKIs) have been developed to target tumors with an EGFR
Autor:
Solene Granjeon-Noriot, Christian Pasquali, Igor Faddeenkov, Jean-Pierre Boissel, Riad Kahoul, Alexander Kulesza, Natacha Go, Aude Chevalier, Ben Min-Woo Illigens, Lorenz Lehr, Daniel Šmít, Claire Couty, Simon Arsène
Clinical research in infectious respiratory diseases has been profoundly affected by non-pharmaceutical interventions (NPIs) against COVID-19. On top of trial delays or even discontinuation which have been observed in all disease areas, NPIs altered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed2a27ee2aa52bbf923c6f8610acc274
https://doi.org/10.1101/2021.11.09.21266145
https://doi.org/10.1101/2021.11.09.21266145
Autor:
Natacha Go, Aude Chevalier, Lorenz Lehr, Igor Faddeenkov, Simon Arsène, Claire Couty, Christian Pasquali, Solene Granjeon-Noriot, Alexander Kulesza
Publikováno v:
Paediatric respiratory infection and immun..
Prophylaxis of RTI in children could have a large impact on hospitalizations, antibiotics overuse or asthma inception but options for vaccination are still limited. The bacterial lysate OM-85 (Broncho-Vaxom®) can significantly prevent RTIs in the pa